Clinical Trial Update: Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B [Phase 4]

View source ↗

Summary

A Phase 4 prospective cohort trial is evaluating PEG-IFN-α-2b to improve clinical cure rates in pediatric patients with chronic hepatitis B; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• PEG-IFN-α-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: HBV, Chronic Hepatitis B Virus | Phase 4 | Status: NOT_YET_RECRUITING